RIZVI SYED ALI-AAMIR (Chief Medical Officer) reported 1 transaction at POSEIDA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/8/2025ACC: 0001415889-25-001083
Officer· Chief Medical Officer
Since Apr 2024
-435K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
435K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−185K
Price / share
—
Trade value
—
% of position
New position
1/8/2025
185K→0.00
Total
Net shares
−185K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2025 | U · U | −185K | — | — | New position | 185K | 0.00 |
| Total | −185K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250K shares
Shares
−250K
Strike price
3.10
Held after
0.00
Exercisable
—
1/8/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock250K shares | 1/8/2025 | D · Disposition | −250K | 3.10 | — | 0.00 |